Despite advances in the understanding of IL-13Rα2 biology in glioma tumors and clinical trials targeting this receptor for therapy, the functional significance of IL-13Rα2 expression in malignant glioblastoma is not well understood. Here, IL13RA2 is linked to central nervous system cancer.